Central Nervous System Agents in Medicinal Chemistry
Title:Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1)
Volume: 15 Issue: 2
Author(s): Gian L. Mariottini
Affiliation:
Export Options
About this article
Cite this article as:
Mariottini L. Gian, Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1), Central Nervous System Agents in Medicinal Chemistry 2015; 15 (2) . https://dx.doi.org/10.2174/187152491502150525114900
DOI https://dx.doi.org/10.2174/187152491502150525114900 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
35
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Overview and Future Perspectives of Cholinergic Therapy in Alzheimers Disease
Current Drug Therapy Exploiting Anti-Inflammation Effects of Flavonoids in Chronic Inflammatory Diseases
Current Pharmaceutical Design Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) Patent Review
Combinatorial Chemistry & High Throughput Screening Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence
CNS & Neurological Disorders - Drug Targets Geniposide Attenuates Oligomeric Aβ<sub>1-42</sub>-Induced Inflammatory Response by Targeting RAGE-Dependent Signaling in BV2 Cells
Current Alzheimer Research Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2
Current Medicinal Chemistry Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry Diminished Renal Function and the Incidence of Heart Failure
Current Cardiology Reviews De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Infectious Agents and Neurodegenerative Diseases: Exploring the Links
Current Topics in Medicinal Chemistry Serum Levels of IL-6, TNF-α and IL-10 as Early Predictors of Mortality in Trauma Hemorrhagic Shock Patients
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Fibrinolysis: The Key to New Pathogenetic Mechanisms
Current Medicinal Chemistry CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells
Current Molecular Medicine Early Detection, Intervention, and Prevention of Psychosis Program: Rationale, Design, and Sample Description
Adolescent Psychiatry Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Current Alzheimer Research ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
Current Neuropharmacology Cardiac Tissue Engineering
Recent Patents on Regenerative Medicine